Clinical Trial

Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study is to investigate investigate the safety and efficacy of Double plasma molecular adsorption system with sequential low-dose plasma exchange in treating hepatitis B virus-related acute-on-chronic liver failure.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-10-20; most recent amendment 2024-11-26.
Status change: Not Yet Recruiting → Recruiting 2021-06-19
Trial Details
NCT Number NCT04597164
Lead Sponsor Third Affiliated Hospital, Sun Yat-Sen University
Conditions Hepatitis B, Chronic, Acute-On-Chronic Liver Failure
Enrollment 200 participants
Start Date 2020-12-22
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-29